BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34342940)

  • 1. Down-regulation of Polo-like kinase 4 (PLK4) induces G1 arrest via activation of the p38/p53/p21 signaling pathway in bladder cancer.
    Yang Z; Sun H; Ma W; Wu K; Peng G; Ou T; Wu S
    FEBS Open Bio; 2021 Sep; 11(9):2631-2646. PubMed ID: 34342940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of centrosome protein TACC3 induces G1 arrest and cell death through activation of p38-p53-p21 stress signaling pathway.
    Suhail TV; Singh P; Manna TK
    Eur J Cell Biol; 2015 Feb; 94(2):90-100. PubMed ID: 25613365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway.
    Chen S; Zhou Q; Guo Z; Wang Y; Wang L; Liu X; Lu M; Ju L; Xiao Y; Wang X
    J Cell Mol Med; 2020 Jan; 24(2):1804-1821. PubMed ID: 31821699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p38 Mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint.
    Lafarga V; Cuadrado A; Lopez de Silanes I; Bengoechea R; Fernandez-Capetillo O; Nebreda AR
    Mol Cell Biol; 2009 Aug; 29(16):4341-51. PubMed ID: 19528229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.
    Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT
    Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.
    Wu G; Lin N; Xu L; Liu B; Feitelson MA
    BMC Cancer; 2013 Mar; 13():167. PubMed ID: 23537372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.
    Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S
    J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect.
    Lei Q; Xiong L; Xia Y; Feng Z; Gao T; Wei W; Song X; Ye T; Wang N; Peng C; Li Z; Liu Z; Yu L
    Cell Death Dis; 2018 Oct; 9(11):1066. PubMed ID: 30337519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of PLK4 expression induces apoptosis and G0/G1-phase cell cycle arrest in keloid fibroblasts.
    Huang RL; Liu C; Fu R; Yan Y; Yang J; Wang X; Li Q
    Cell Prolif; 2022 Jul; 55(7):e13271. PubMed ID: 35670224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein.
    Fischer M; Quaas M; Wintsche A; Müller GA; Engeland K
    Nucleic Acids Res; 2014 Jan; 42(1):163-80. PubMed ID: 24071582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Widdrol activates DNA damage checkpoint through the signaling Chk2-p53-Cdc25A-p21-MCM4 pathway in HT29 cells.
    Yun HJ; Hyun SK; Park JH; Kim BW; Kwon HJ
    Mol Cell Biochem; 2012 Apr; 363(1-2):281-9. PubMed ID: 22160829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neferine, an alkaloid ingredient in lotus seed embryo, inhibits proliferation of human osteosarcoma cells by promoting p38 MAPK-mediated p21 stabilization.
    Zhang X; Liu Z; Xu B; Sun Z; Gong Y; Shao C
    Eur J Pharmacol; 2012 Feb; 677(1-3):47-54. PubMed ID: 22227330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
    Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
    Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
    Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
    J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of centrosome integrity induces p38-p53-p21-dependent G1-S arrest.
    Mikule K; Delaval B; Kaldis P; Jurcyzk A; Hergert P; Doxsey S
    Nat Cell Biol; 2007 Feb; 9(2):160-70. PubMed ID: 17330329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
    Xie H; Li C; Dang Q; Chang LS; Li L
    Oncotarget; 2016 Jan; 7(2):1341-53. PubMed ID: 26625310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
    Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function.
    Lo PK; Lee JS; Sukumar S
    Cell Signal; 2012 Jan; 24(1):316-24. PubMed ID: 21964066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Polo-like kinase 4 induces mitotic defects and DNA damage in diffuse large B-cell lymphoma.
    Zhao Y; Yang J; Liu J; Cai Y; Han Y; Hu S; Ren S; Zhou X; Wang X
    Cell Death Dis; 2021 Jun; 12(7):640. PubMed ID: 34162828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
    Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
    Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.